Phosphodiesterase 4 Inhibitor
37 drugs across 13 manufacturers|26 Generic,11 Brand
The Phosphodiesterase 4 Inhibitor class contains 37 NDCs from 13 manufacturers (26 generic, 11 brand), at an average NADAC of $9.00 per unit. Every drug, manufacturer, and price in this FDA-defined pharmacologic class is listed below.
Total Drugs
37
26G / 11B
Manufacturers
13
Avg $9.0029/unit
Avg 7d Change
+0.62%
Across 30 drugs with changes
7d Activity
of 37 total drugs
Class Price Trend
Monthly average NADAC price per unit, split by generic and brand
Manufacturer Breakdown
13 manufacturers producing drugs in this therapeutic class(1 pricing outlier)
and 1 more manufacturer
Frequently Asked Questions
How many drugs are in the Phosphodiesterase 4 Inhibitor class?
The Phosphodiesterase 4 Inhibitor class contains 37 NDCs from 13 manufacturers — 26 generic and 11 brand products.
What is the average price of Phosphodiesterase 4 Inhibitor drugs?
The average NADAC for the Phosphodiesterase 4 Inhibitor class is $9.0029 per unit across 37 NDCs.
Is generic cheaper than brand in the Phosphodiesterase 4 Inhibitor class?
Among products priced per EA, the average generic NADAC in this class is $0.8980, versus $40.0448 for brand — brand products average about 45× the generic price.
Which manufacturers make Phosphodiesterase 4 Inhibitor drugs?
13 manufacturers make drugs in the Phosphodiesterase 4 Inhibitor class. Ranked by number of NDCs, the largest are Major Pharmaceuticals (5), AstraZeneca Pharmaceuticals LP (4), Camber Pharmaceuticals Inc. (4), Zydus Pharmaceuticals (USA) Inc. (4), Novadoz Pharmaceuticals LLC (4).
How has Phosphodiesterase 4 Inhibitor pricing changed recently?
Over the past 7 days, 27 NDCs in this class rose and 3 fell, with a class-wide average change of +0.6%.